Segment, Geographic and Other Revenue Information - Schedule of Significant Biopharma Segment Expenses (Details) - USD ($) $ in Millions |
3 Months Ended | 9 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Sep. 27, 2026 |
Sep. 28, 2025 |
Sep. 27, 2026 |
Sep. 28, 2025 |
|||||||
| Segment Reporting [Line Items] | ||||||||||
| Revenues: | $ 16,583 | $ 16,654 | $ 46,067 | $ 45,022 | ||||||
| Cost of sales | [1] | 4,028 | 4,172 | 11,668 | 10,795 | |||||
| Selling, informational and administrative expenses | [1] | 3,279 | 3,186 | 9,651 | 9,632 | |||||
| Research and development expenses | [1] | 3,016 | 2,546 | 8,315 | 7,231 | |||||
| Acquired in-process research and development expenses | 669 | 1,390 | 822 | 1,401 | ||||||
| Other (income)/deductions––net | 288 | 517 | 4,866 | 2,210 | ||||||
| Income from continuing operations before provision/(benefit) for taxes on income | [2] | 3,385 | 3,334 | 5,902 | 9,162 | |||||
| Biopharma [Member] | ||||||||||
| Segment Reporting [Line Items] | ||||||||||
| Revenues: | [3] | 16,283 | 16,310 | 45,105 | 44,056 | |||||
| Cost of sales | 3,456 | 3,526 | 9,678 | 8,915 | ||||||
| Selling, informational and administrative expenses | 2,300 | 2,210 | 6,775 | 6,739 | ||||||
| Research and development expenses | 2,580 | 2,185 | 7,094 | 6,235 | ||||||
| Acquired in-process research and development expenses | 19 | 40 | 172 | 51 | ||||||
| Other (income)/deductions––net | (314) | (120) | (581) | (313) | ||||||
| Income from continuing operations before provision/(benefit) for taxes on income | $ 8,241 | $ 8,469 | $ 21,967 | $ 22,429 | ||||||
| ||||||||||
| X | ||||||||||
- Definition The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of writeoff for research and development asset acquired in transaction other than business combination or from joint venture formation or both. Includes, but is not limited to, software to be sold, leased, or marketed. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|